Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global RNA Medicine Market Growth (Status and Outlook) 2022-2028

  • LP 4973499
  • 113 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of RNA Medicine will have significant change from previous year. According to our (LP Information) latest study, the global RNA Medicine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global RNA Medicine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States RNA Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global RNA Medicine market, reaching US$ million by the year 2028. As for the Europe RNA Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main RNA Medicine players cover Pfizer, Roche, Sanofi-Aventis, and Abbott Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of RNA Medicine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

siRNA

ASO

miRNA

Nucleic Acid Aptamers

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Cancer

Diabetes

Tuberculosis

Cardiovascular Diseases

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Pfizer

Roche

Sanofi-Aventis

Abbott Laboratories

Arrowhead Pharmaceuticals

Benitec Biopharma

Calimmune Inc

Dicerna

Gradalis

Quark

RXi

Senesco

Silence Therapeutics

Silenseed

Tekmira

Alnylam Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNA Medicine Market Size 2017-2028

2.1.2 RNA Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 RNA Medicine Segment by Type

2.2.1 siRNA

2.2.2 ASO

2.2.3 miRNA

2.2.4 Nucleic Acid Aptamers

2.3 RNA Medicine Market Size by Type

2.3.1 RNA Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global RNA Medicine Market Size Market Share by Type (2017-2022)

2.4 RNA Medicine Segment by Application

2.4.1 Cancer

2.4.2 Diabetes

2.4.3 Tuberculosis

2.4.4 Cardiovascular Diseases

2.4.5 Others

2.5 RNA Medicine Market Size by Application

2.5.1 RNA Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global RNA Medicine Market Size Market Share by Application (2017-2022)

3 RNA Medicine Market Size by Player

3.1 RNA Medicine Market Size Market Share by Players

3.1.1 Global RNA Medicine Revenue by Players (2020-2022)

3.1.2 Global RNA Medicine Revenue Market Share by Players (2020-2022)

3.2 Global RNA Medicine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 RNA Medicine by Regions

4.1 RNA Medicine Market Size by Regions (2017-2022)

4.2 Americas RNA Medicine Market Size Growth (2017-2022)

4.3 APAC RNA Medicine Market Size Growth (2017-2022)

4.4 Europe RNA Medicine Market Size Growth (2017-2022)

4.5 Middle East & Africa RNA Medicine Market Size Growth (2017-2022)

5 Americas

5.1 Americas RNA Medicine Market Size by Country (2017-2022)

5.2 Americas RNA Medicine Market Size by Type (2017-2022)

5.3 Americas RNA Medicine Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNA Medicine Market Size by Region (2017-2022)

6.2 APAC RNA Medicine Market Size by Type (2017-2022)

6.3 APAC RNA Medicine Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe RNA Medicine by Country (2017-2022)

7.2 Europe RNA Medicine Market Size by Type (2017-2022)

7.3 Europe RNA Medicine Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNA Medicine by Region (2017-2022)

8.2 Middle East & Africa RNA Medicine Market Size by Type (2017-2022)

8.3 Middle East & Africa RNA Medicine Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global RNA Medicine Market Forecast

10.1 Global RNA Medicine Forecast by Regions (2023-2028)

10.1.1 Global RNA Medicine Forecast by Regions (2023-2028)

10.1.2 Americas RNA Medicine Forecast

10.1.3 APAC RNA Medicine Forecast

10.1.4 Europe RNA Medicine Forecast

10.1.5 Middle East & Africa RNA Medicine Forecast

10.2 Americas RNA Medicine Forecast by Country (2023-2028)

10.2.1 United States RNA Medicine Market Forecast

10.2.2 Canada RNA Medicine Market Forecast

10.2.3 Mexico RNA Medicine Market Forecast

10.2.4 Brazil RNA Medicine Market Forecast

10.3 APAC RNA Medicine Forecast by Region (2023-2028)

10.3.1 China RNA Medicine Market Forecast

10.3.2 Japan RNA Medicine Market Forecast

10.3.3 Korea RNA Medicine Market Forecast

10.3.4 Southeast Asia RNA Medicine Market Forecast

10.3.5 India RNA Medicine Market Forecast

10.3.6 Australia RNA Medicine Market Forecast

10.4 Europe RNA Medicine Forecast by Country (2023-2028)

10.4.1 Germany RNA Medicine Market Forecast

10.4.2 France RNA Medicine Market Forecast

10.4.3 UK RNA Medicine Market Forecast

10.4.4 Italy RNA Medicine Market Forecast

10.4.5 Russia RNA Medicine Market Forecast

10.5 Middle East & Africa RNA Medicine Forecast by Region (2023-2028)

10.5.1 Egypt RNA Medicine Market Forecast

10.5.2 South Africa RNA Medicine Market Forecast

10.5.3 Israel RNA Medicine Market Forecast

10.5.4 Turkey RNA Medicine Market Forecast

10.5.5 GCC Countries RNA Medicine Market Forecast

10.6 Global RNA Medicine Forecast by Type (2023-2028)

10.7 Global RNA Medicine Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer RNA Medicine Product Offered

11.1.3 Pfizer RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 Roche

11.2.1 Roche Company Information

11.2.2 Roche RNA Medicine Product Offered

11.2.3 Roche RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Roche Main Business Overview

11.2.5 Roche Latest Developments

11.3 Sanofi-Aventis

11.3.1 Sanofi-Aventis Company Information

11.3.2 Sanofi-Aventis RNA Medicine Product Offered

11.3.3 Sanofi-Aventis RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Sanofi-Aventis Main Business Overview

11.3.5 Sanofi-Aventis Latest Developments

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Information

11.4.2 Abbott Laboratories RNA Medicine Product Offered

11.4.3 Abbott Laboratories RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Abbott Laboratories Main Business Overview

11.4.5 Abbott Laboratories Latest Developments

11.5 Arrowhead Pharmaceuticals

11.5.1 Arrowhead Pharmaceuticals Company Information

11.5.2 Arrowhead Pharmaceuticals RNA Medicine Product Offered

11.5.3 Arrowhead Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Arrowhead Pharmaceuticals Main Business Overview

11.5.5 Arrowhead Pharmaceuticals Latest Developments

11.6 Benitec Biopharma

11.6.1 Benitec Biopharma Company Information

11.6.2 Benitec Biopharma RNA Medicine Product Offered

11.6.3 Benitec Biopharma RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Benitec Biopharma Main Business Overview

11.6.5 Benitec Biopharma Latest Developments

11.7 Calimmune Inc

11.7.1 Calimmune Inc Company Information

11.7.2 Calimmune Inc RNA Medicine Product Offered

11.7.3 Calimmune Inc RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Calimmune Inc Main Business Overview

11.7.5 Calimmune Inc Latest Developments

11.8 Dicerna

11.8.1 Dicerna Company Information

11.8.2 Dicerna RNA Medicine Product Offered

11.8.3 Dicerna RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Dicerna Main Business Overview

11.8.5 Dicerna Latest Developments

11.9 Gradalis

11.9.1 Gradalis Company Information

11.9.2 Gradalis RNA Medicine Product Offered

11.9.3 Gradalis RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Gradalis Main Business Overview

11.9.5 Gradalis Latest Developments

11.10 Quark

11.10.1 Quark Company Information

11.10.2 Quark RNA Medicine Product Offered

11.10.3 Quark RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Quark Main Business Overview

11.10.5 Quark Latest Developments

11.11 RXi

11.11.1 RXi Company Information

11.11.2 RXi RNA Medicine Product Offered

11.11.3 RXi RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 RXi Main Business Overview

11.11.5 RXi Latest Developments

11.12 Senesco

11.12.1 Senesco Company Information

11.12.2 Senesco RNA Medicine Product Offered

11.12.3 Senesco RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Senesco Main Business Overview

11.12.5 Senesco Latest Developments

11.13 Silence Therapeutics

11.13.1 Silence Therapeutics Company Information

11.13.2 Silence Therapeutics RNA Medicine Product Offered

11.13.3 Silence Therapeutics RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Silence Therapeutics Main Business Overview

11.13.5 Silence Therapeutics Latest Developments

11.14 Silenseed

11.14.1 Silenseed Company Information

11.14.2 Silenseed RNA Medicine Product Offered

11.14.3 Silenseed RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Silenseed Main Business Overview

11.14.5 Silenseed Latest Developments

11.15 Tekmira

11.15.1 Tekmira Company Information

11.15.2 Tekmira RNA Medicine Product Offered

11.15.3 Tekmira RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Tekmira Main Business Overview

11.15.5 Tekmira Latest Developments

11.16 Alnylam Pharmaceuticals

11.16.1 Alnylam Pharmaceuticals Company Information

11.16.2 Alnylam Pharmaceuticals RNA Medicine Product Offered

11.16.3 Alnylam Pharmaceuticals RNA Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Alnylam Pharmaceuticals Main Business Overview

11.16.5 Alnylam Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. RNA Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of siRNA

Table 3. Major Players of ASO

Table 4. Major Players of miRNA

Table 5. Major Players of Nucleic Acid Aptamers

Table 6. RNA Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global RNA Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global RNA Medicine Market Size Market Share by Type (2017-2022)

Table 9. RNA Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global RNA Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global RNA Medicine Market Size Market Share by Application (2017-2022)

Table 12. Global RNA Medicine Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global RNA Medicine Revenue Market Share by Player (2020-2022)

Table 14. RNA Medicine Key Players Head office and Products Offered

Table 15. RNA Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global RNA Medicine Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global RNA Medicine Market Size Market Share by Regions (2017-2022)

Table 20. Americas RNA Medicine Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas RNA Medicine Market Size Market Share by Country (2017-2022)

Table 22. Americas RNA Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas RNA Medicine Market Size Market Share by Type (2017-2022)

Table 24. Americas RNA Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas RNA Medicine Market Size Market Share by Application (2017-2022)

Table 26. APAC RNA Medicine Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC RNA Medicine Market Size Market Share by Region (2017-2022)

Table 28. APAC RNA Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC RNA Medicine Market Size Market Share by Type (2017-2022)

Table 30. APAC RNA Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC RNA Medicine Market Size Market Share by Application (2017-2022)

Table 32. Europe RNA Medicine Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe RNA Medicine Market Size Market Share by Country (2017-2022)

Table 34. Europe RNA Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe RNA Medicine Market Size Market Share by Type (2017-2022)

Table 36. Europe RNA Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe RNA Medicine Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa RNA Medicine Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa RNA Medicine Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa RNA Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa RNA Medicine Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa RNA Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa RNA Medicine Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of RNA Medicine

Table 45. Key Market Challenges & Risks of RNA Medicine

Table 46. Key Industry Trends of RNA Medicine

Table 47. Global RNA Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global RNA Medicine Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global RNA Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global RNA Medicine Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global RNA Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global RNA Medicine Market Size Market Share Forecast by Application (2023-2028)

Table 53. Pfizer Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 54. Pfizer RNA Medicine Product Offered

Table 55. Pfizer RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Pfizer Main Business

Table 57. Pfizer Latest Developments

Table 58. Roche Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 59. Roche RNA Medicine Product Offered

Table 60. Roche Main Business

Table 61. Roche RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Roche Latest Developments

Table 63. Sanofi-Aventis Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 64. Sanofi-Aventis RNA Medicine Product Offered

Table 65. Sanofi-Aventis Main Business

Table 66. Sanofi-Aventis RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Sanofi-Aventis Latest Developments

Table 68. Abbott Laboratories Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 69. Abbott Laboratories RNA Medicine Product Offered

Table 70. Abbott Laboratories Main Business

Table 71. Abbott Laboratories RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Abbott Laboratories Latest Developments

Table 73. Arrowhead Pharmaceuticals Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 74. Arrowhead Pharmaceuticals RNA Medicine Product Offered

Table 75. Arrowhead Pharmaceuticals Main Business

Table 76. Arrowhead Pharmaceuticals RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Arrowhead Pharmaceuticals Latest Developments

Table 78. Benitec Biopharma Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 79. Benitec Biopharma RNA Medicine Product Offered

Table 80. Benitec Biopharma Main Business

Table 81. Benitec Biopharma RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Benitec Biopharma Latest Developments

Table 83. Calimmune Inc Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 84. Calimmune Inc RNA Medicine Product Offered

Table 85. Calimmune Inc Main Business

Table 86. Calimmune Inc RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Calimmune Inc Latest Developments

Table 88. Dicerna Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 89. Dicerna RNA Medicine Product Offered

Table 90. Dicerna Main Business

Table 91. Dicerna RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Dicerna Latest Developments

Table 93. Gradalis Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 94. Gradalis RNA Medicine Product Offered

Table 95. Gradalis Main Business

Table 96. Gradalis RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Gradalis Latest Developments

Table 98. Quark Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 99. Quark RNA Medicine Product Offered

Table 100. Quark Main Business

Table 101. Quark RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Quark Latest Developments

Table 103. RXi Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 104. RXi RNA Medicine Product Offered

Table 105. RXi RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. RXi Main Business

Table 107. RXi Latest Developments

Table 108. Senesco Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 109. Senesco RNA Medicine Product Offered

Table 110. Senesco Main Business

Table 111. Senesco RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Senesco Latest Developments

Table 113. Silence Therapeutics Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 114. Silence Therapeutics RNA Medicine Product Offered

Table 115. Silence Therapeutics Main Business

Table 116. Silence Therapeutics RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Silence Therapeutics Latest Developments

Table 118. Silenseed Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 119. Silenseed RNA Medicine Product Offered

Table 120. Silenseed Main Business

Table 121. Silenseed RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Silenseed Latest Developments

Table 123. Tekmira Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 124. Tekmira RNA Medicine Product Offered

Table 125. Tekmira Main Business

Table 126. Tekmira RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Tekmira Latest Developments

Table 128. Alnylam Pharmaceuticals Details, Company Type, RNA Medicine Area Served and Its Competitors

Table 129. Alnylam Pharmaceuticals RNA Medicine Product Offered

Table 130. Alnylam Pharmaceuticals Main Business

Table 131. Alnylam Pharmaceuticals RNA Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. Alnylam Pharmaceuticals Latest Developments

List of Figures

Figure 1. RNA Medicine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global RNA Medicine Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global RNA Medicine Market Size Market Share by Type in 2021

Figure 7. RNA Medicine in Cancer

Figure 8. Global RNA Medicine Market: Cancer (2017-2022) & ($ Millions)

Figure 9. RNA Medicine in Diabetes

Figure 10. Global RNA Medicine Market: Diabetes (2017-2022) & ($ Millions)

Figure 11. RNA Medicine in Tuberculosis

Figure 12. Global RNA Medicine Market: Tuberculosis (2017-2022) & ($ Millions)

Figure 13. RNA Medicine in Cardiovascular Diseases

Figure 14. Global RNA Medicine Market: Cardiovascular Diseases (2017-2022) & ($ Millions)

Figure 15. RNA Medicine in Others

Figure 16. Global RNA Medicine Market: Others (2017-2022) & ($ Millions)

Figure 17. Global RNA Medicine Market Size Market Share by Application in 2021

Figure 18. Global RNA Medicine Revenue Market Share by Player in 2021

Figure 19. Global RNA Medicine Market Size Market Share by Regions (2017-2022)

Figure 20. Americas RNA Medicine Market Size 2017-2022 ($ Millions)

Figure 21. APAC RNA Medicine Market Size 2017-2022 ($ Millions)

Figure 22. Europe RNA Medicine Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa RNA Medicine Market Size 2017-2022 ($ Millions)

Figure 24. Americas RNA Medicine Value Market Share by Country in 2021

Figure 25. Americas RNA Medicine Consumption Market Share by Type in 2021

Figure 26. Americas RNA Medicine Market Size Market Share by Application in 2021

Figure 27. United States RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC RNA Medicine Market Size Market Share by Region in 2021

Figure 32. APAC RNA Medicine Market Size Market Share by Application in 2021

Figure 33. China RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 37. India RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe RNA Medicine Market Size Market Share by Country in 2021

Figure 40. Europe RNA Medicine Market Size Market Share by Type in 2021

Figure 41. Europe RNA Medicine Market Size Market Share by Application in 2021

Figure 42. Germany RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 43. France RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa RNA Medicine Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa RNA Medicine Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa RNA Medicine Market Size Market Share by Application in 2021

Figure 50. Egypt RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country RNA Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 56. APAC RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 57. Europe RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 59. United States RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 60. Canada RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 61. Mexico RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 62. Brazil RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 63. China RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 64. Japan RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 65. Korea RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 67. India RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 68. Australia RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 69. Germany RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 70. France RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 71. UK RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 72. Italy RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 73. Russia RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 74. Spain RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 75. Egypt RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 76. South Africa RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 77. Israel RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 78. Turkey RNA Medicine Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries RNA Medicine Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390